Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Systematic Review

Published on 02 Feb 2024

Global trends in research on MOG antibody-associated disease: bibliometrics and visualization analysis

in Multiple Sclerosis and Neuroimmunology

Shuhan Zheng
Yang Wang
Jiaming Geng
Xueyan Liu
Liang Huo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1278867

5,151 views
4 citations

Original Research

Published on 29 Jan 2024

Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study

in Multiple Sclerosis and Neuroimmunology

Chao Tang
Xiaoyang Lei
Yaqi Ding
Sushuang Yang
Yayu Ma
Dian He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1339649

11,998 views
18 citations

Review

Published on 29 Jan 2024

Impact of inflammation and Treg cell regulation on neuropathic pain in spinal cord injury: mechanisms and therapeutic prospects

in Multiple Sclerosis and Neuroimmunology

Chunjia Zhang
Yan Li
Yan Yu
Zehui Li
Xin Xu
Zuliyaer Talifu
Wubo Liu
Degang Yang
Feng Gao
Song Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1334828

6,270 views
14 citations

Original Research

Published on 29 Jan 2024

Risk factors of neuropathic pain in multiple sclerosis: a retrospective case-cohort study

in Multiple Sclerosis and Neuroimmunology

Huiying Ouyang
Xiaojun Li
Haoyou Xu
Yibo Zhan
Zequan Zheng
Guixian Chen
Zhenzhen Lou
Haoxuan Chen
Jiahui Zhang
Hui Mao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1309583

2,563 views
6 citations

Brief Research Report

Published on 25 Jan 2024

Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia

in Multiple Sclerosis and Neuroimmunology

Liyuan Guo
Haitao Ren
Siyuan Fan
Xingchen Chao
Mange Liu
Hongzhi Guan
Jing Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1289175

1,872 views
3 citations

Review

Published on 16 Jan 2024

Harnessing filamentous phages for enhanced stroke recovery

in Multiple Sclerosis and Neuroimmunology

Yang Li
Kai-di Yang
De-cai Kong
Xiao-meng Li
Hao-yu Duan
Jun-feng Ye

Frontiers in Immunology

doi 10.3389/fimmu.2023.1343788

2,932 views
1 citation

Correction

Published on 16 Jan 2024

Corrigendum: Plasma exchange for two patients with autoimmune GFAP astrocytopathy with rapid progression to respiratory failure: a case report

in Multiple Sclerosis and Neuroimmunology

Jing Du
Shugang Cao
Lan Xia
Qi Li
Yanghua Tian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1366725

884 views

Original Research

Published on 15 Jan 2024

Microglia depletion/repopulation does not affect light-induced retinal degeneration in mice

in Multiple Sclerosis and Neuroimmunology

Nils Laudenberg
Urbanus Muthai Kinuthia
Thomas Langmann

Frontiers in Immunology

doi 10.3389/fimmu.2023.1345382

3,836 views
7 citations

Editorial

Published on 11 Jan 2024

Editorial: The molecular basis of programmed cell death and neuroinflammation in neurodegenerative diseases

in Multiple Sclerosis and Neuroimmunology

Chetna Soni
Antariksh Tyagi
Xusheng Wang
Ramkumar Mathur

Frontiers in Immunology

doi 10.3389/fimmu.2023.1359136

1,318 views
3 citations

Original Research

Published on 11 Jan 2024

Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value

in Multiple Sclerosis and Neuroimmunology

Hua-Bao Cai
Meng-Yu Zhao
Xin-Han Li
Yu-Qing Li
Tian-Hang Yu
Cun-Zhi Wang
Li-Na Wang
Wan-Yan Xu
Bo Liang
Yong-Ping Cai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1336187

7,568 views
6 citations

Original Research

Published on 08 Jan 2024

Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD

in Multiple Sclerosis and Neuroimmunology

Lei Wang
Ruihong Xia
Xiangliang Li
Jingli Shan
Shengjun Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1293100

3,016 views
2 citations

Editorial

Published on 05 Jan 2024

Editorial: Epstein-Barr Virus and multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Gunnar Houen
Klemens Ruprecht

Frontiers in Immunology

doi 10.3389/fimmu.2023.1330181

2,305 views

Editorial

Published on 19 Dec 2023

Editorial: Innovative OMICs-technology applications to reach a diagnosis and bring new therapies to immune-mediated neurological diseases

in Multiple Sclerosis and Neuroimmunology

Laura Otero-Ortega
Mireya Fernández-Fournier
Haritz Irizar
David Otaegui
Exuperio Díez-Tejedor

Frontiers in Immunology

doi 10.3389/fimmu.2023.1348986

928 views
1 citation

Brief Research Report

Published on 19 Dec 2023

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study

in Multiple Sclerosis and Neuroimmunology

Harald Hegen
Klaus Berek
Paola Cavalla
Mikael Christiansen
Andreja Emeršič
Massimiliano Di Filippo
Lorenzo Gaetani
Michaela Hassler
Cyra Leurs
Dejan Milosavljevic

Frontiers in Immunology

doi 10.3389/fimmu.2023.1327947

4,050 views
8 citations

Original Research

Published on 13 Dec 2023

Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing–remitting multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Ivan Arisi
Leonardo Malimpensa
Valeria Manzini
Rossella Brandi
Tommaso Gosetti di Sturmeck
Chiara D’Amelio
Sebastiano Crisafulli
Gina Ferrazzano
Daniele Belvisi
Francesca Malerba

Frontiers in Immunology

doi 10.3389/fimmu.2023.1234869

3,588 views
6 citations

Original Research

Published on 12 Dec 2023

Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China

in Multiple Sclerosis and Neuroimmunology

Teng Huang
Fei Liu
Baojie Wang
Chunjuan Wang
Maolin Hao
Shougang Guo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1213532

3,649 views
8 citations